A myelodysplastic syndrome characterized by the presence of 5-19% myeloblasts in the bone marrow or 2-19% blasts in the peripheral blood. It includes two categories: raeb-1and raeb-2. Cases with significant bone marrow reticulin fibrosis are called raeb with fibrosis.
Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.
D46.2 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
The 2023 edition of ICD-10-CM D46.2 became effective on October 1, 2022.
This is the American ICD-10-CM version of D46.2 – other international versions of ICD-10 D46.2 may differ.